{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T16:43:16Z","timestamp":1787071396250,"version":"build-2736575974"},"reference-count":18,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,10]]},"abstract":"<jats:p>\n                    <jats:bold>Introduction:<\/jats:bold>\n                    Patients with hematologic malignancies are at increased risk for acute respiratory failure (ARF), which is a leading cause of intensive care units admission and mortality in this population. This study aimed to characterize the epidemiology, clinical outcomes, and healthcare utilization associated with ARF in hospitalized patients with hematologic malignancies, using a nationally representative dataset.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Methods:<\/jats:bold>\n                    We conducted a retrospective cohort study using the 2016\u20132019 National Inpatient Sample. Adult hospitalizations with hematologic malignancies were identified using International Classification of Disease, Tenth Revision, Clinical Modification codes and stratified by presence of ARF and by use of invasive mechanical ventilation (IMV).\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Results:<\/jats:bold>\n                    Among 2,427,924 hospitalizations for hematologic malignancies, 304,515 (12.5%) had ARF. Compared to non-ARF admissions, admissions with ARF were older, with a mean age of 70.1 versus 65.9 years, had more comorbidities, with 61.1% having a Charlson comorbidity index greater than 3 compared to 40.9%, and experienced higher rates of sepsis (71.6% vs. 38.3%) and acute kidney injury (AKI) (43.5% vs. 20.1%). In-hospital mortality among admissions with ARF was 22.7% compared to 2.2% in those without ARF. These admissions also had longer hospital stays (10.95 days vs. 6.58 days) and incurred higher hospital costs ($37,645 vs. $19,505). Among admissions with ARF, 84,260 (27.7%) required IMV. This subgroup had the highest mortality at 49.7%, a mean length of stay of 16.3 days, and incurred the highest hospital costs at $69,923. IMV use was also associated with higher complication rates, including sepsis (80.4%) and AKI (62.4%). Increased age, AKI, and neutropenia were independent predictors of in-hospital mortality among admission with hematological malignancies who required invasive mechanical ventilation.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Conclusion:<\/jats:bold>\n                    ARF affects more than one in 10 hospitalized patients with hematologic malignancies. Although improved compared to historical data, it remains linked to increased mortality and healthcare utilization, particularly among those requiring IMV. These findings highlight the need for early risk stratification and targeted interventions to improve outcomes in this high-risk population.\n                  <\/jats:p>","DOI":"10.4103\/hemoncstem.hemoncstem-d-25-00032","type":"journal-article","created":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T10:00:42Z","timestamp":1772791242000},"page":"146-154","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Epidemiology and Outcomes of Hospitalized Patients with Hematological Malignancy and Acute Respiratory Failure"],"prefix":"10.4103","volume":"18","author":[{"given":"Anoosha","family":"Ponnapalli","sequence":"first","affiliation":[{"name":"Division of Pulmonary, Critical Care and Sleep Medicine, Wayne State University School of Medicine, Detroit, Michigan, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aditya","family":"Sharma","sequence":"additional","affiliation":[{"name":"Department of Medicine, Wayne State University School of Medicine, Detroit, Michigan, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariam","family":"Fatima","sequence":"additional","affiliation":[{"name":"Department of Medicine, Wayne State University School of Medicine, Detroit, Michigan, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avneet Kaur","family":"Arora","sequence":"additional","affiliation":[{"name":"Department of Medicine, Wayne State University School of Medicine, Detroit, Michigan, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayman O.","family":"Soubani","sequence":"additional","affiliation":[{"name":"Division of Pulmonary, Critical Care and Sleep Medicine, Wayne State University School of Medicine, Detroit, Michigan, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,3,6]]},"reference":[{"key":"R1-20260708","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1182\/blood.2023021414","article-title":"How I manage acute respiratory failure in patients with hematological malignancies","volume":"143","author":"Azoulay","year":"2024","journal-title":"Blood"},{"key":"R2-20260708","doi-asserted-by":"crossref","first-page":"2810","DOI":"10.1200\/JCO.2012.47.2365","article-title":"Outcomes of critically ill patients with hematologic malignancies: prospective multicenter data from France and Belgium-a groupe de recherche respiratoire en r\u00e9animation onco-h\u00e9matologique study","volume":"31","author":"Azoulay","year":"2013","journal-title":"J Clin Oncol"},{"key":"R3-20260708","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1177\/0885066615601046","article-title":"Management of acute respiratory failure in patients with hematological malignancy","volume":"31","author":"Vadde","year":"2016","journal-title":"J Intensive Care Med"},{"key":"R4-20260708","doi-asserted-by":"crossref","first-page":"78.e1","DOI":"10.1016\/j.bbmt.2020.09.035","article-title":"Acute respiratory failure outcomes in patients with hematologic malignancies and hematopoietic cell transplant: a secondary analysis of the EFRAIM study","volume":"27","author":"Munshi","year":"2021","journal-title":"Transplant Cell Ther"},{"key":"R5-20260708","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.mayocp.2023.07.024","article-title":"Outcomes of acute respiratory failure in patients with cancer in the United States","volume":"99","author":"Heybati","year":"2024","journal-title":"Mayo Clin Proc"},{"key":"R6-20260708","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1080\/17476348.2024.2433554","article-title":"Acute respiratory failure in adult patients with acute myeloid leukemia","volume":"18","author":"Chean","year":"2024","journal-title":"Expert Rev Respir Med"},{"key":"R7-20260708","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s13613-015-0070-z","article-title":"Acute respiratory failure in patients with hematological malignancies: outcomes according to initial ventilation strategy. A groupe de recherche respiratoire en r\u00e9animation onco-h\u00e9matologique (Grrr-OH) study","volume":"5","author":"Lemiale","year":"2015","journal-title":"Ann Intensive Care"},{"key":"R8-20260708","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1378\/chest.126.4.1299","article-title":"Outcome in noninvasively and invasively ventilated hematologic patients with acute respiratory failure","volume":"126","author":"Depuydt","year":"2004","journal-title":"Chest"},{"key":"R9-20260708","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s13613-024-01409-9","article-title":"Critically ill adult patients with acute leukemia: a systematic review and meta-analysis","volume":"15","author":"Chean","year":"2025","journal-title":"Ann Intensive Care"},{"key":"R10-20260708","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1007\/s00134-008-1320-4","article-title":"Continued survival gains in recent years among critically ill myeloma patients","volume":"35","author":"Peigne","year":"2009","journal-title":"Intensive Care Med"},{"key":"R11-20260708","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.3109\/10428194.2012.753446","article-title":"Delayed intensive care unit admission is associated with increased mortality in patients with cancer with acute respiratory failure","volume":"54","author":"Mokart","year":"2013","journal-title":"Leuk Lymphoma"},{"key":"R12-20260708","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1186\/s13613-024-01373-4","article-title":"Acute respiratory distress syndrome in patients with hematological malignancies: a one-year retrospective nationwide cohort study","volume":"14","author":"Bris","year":"2024","journal-title":"Ann Intensive Care"},{"key":"R13-20260708","doi-asserted-by":"crossref","first-page":"259","DOI":"10.4103\/atm.ATM_21_17","article-title":"Characteristics and predictors of mortality of patients with hematologic malignancies requiring invasive mechanical ventilation","volume":"12","author":"Al-Dorzi","year":"2017","journal-title":"Ann Thorac Med"},{"key":"R14-20260708","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1177\/175114370800900208","article-title":"The outcome of haematological malignancy in Scottish intensive care units","volume":"9","author":"Cuthbertson","year":"2008","journal-title":"J Intens Care Soc"},{"key":"R15-20260708","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/2110-5820-1-5","article-title":"Intensive care of the cancer patient: recent achievements and remaining challenges","volume":"1","author":"Azoulay","year":"2011","journal-title":"Ann Intensive Care"},{"key":"R16-20260708","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1186\/s13054-018-2076-z","article-title":"Influence of neutropenia on mortality of critically ill cancer patients: results of a meta-analysis on individual data","volume":"22","author":"Georges","year":"2018","journal-title":"Crit Care"},{"key":"R17-20260708","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1378\/chest.13-1870","article-title":"Outcomes for patients with cancer admitted to the ICU requiring ventilatory support: results from a prospective multicenter study","volume":"146","author":"Azevedo","year":"2014","journal-title":"Chest"},{"key":"R18-20260708","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1001\/jama.2017.17653","article-title":"Adherence to methodological standards in research using the national inpatient sample","volume":"318","author":"Khera","year":"2017","journal-title":"JAMA"}],"container-title":["Hematology\/Oncology and Stem Cell Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/hemoncstem.hemoncstem-D-25-00032","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:45:32Z","timestamp":1787067932000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/hemoncstem.hemoncstem-D-25-00032"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":18,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.4103\/hemoncstem.hemoncstem-d-25-00032","relation":{},"ISSN":["1658-3876","2589-0646"],"issn-type":[{"value":"1658-3876","type":"print"},{"value":"2589-0646","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"2025-08-01","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-02-04","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}